Related Experiment Video
Updated: Sep 28, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation
Sandra Hirsch1, M Pia De la Maza, Paulina Yañez
1Institute of Nutrition and Food Technology, University of Chile, Santiago. shirsch@uec.inta.uchile.cl
Insights
Mild hyperhomocysteinemia in young men is not linked to endothelial dysfunction. Vitamin supplementation did not improve endothelial function, suggesting total homocysteine (tHcy) levels may be more related to vitamin B12 than folic acid.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
- Vascular Biology
Background:
- The link between elevated total homocysteine (tHcy) and cardiovascular disease (CVD) requires further clarification.
- Endothelial dysfunction is an early marker of CVD.
Purpose of the Study:
- To investigate the association between hyperhomocysteinemia and endothelial dysfunction in young males without other cardiovascular risk factors.
- To assess the impact of vitamin supplementation on total homocysteine (tHcy) levels and endothelial function.
Main Methods:
- Recruited 20 hyperhomocysteinemic and 20 normohomocysteinemic young males, excluding those with CVD risk factors.
- Measured serum tHcy, vitamin B12, folate, coagulation factors, and LDL oxidation.
- Assessed endothelial-dependent (EDD) and independent dilatation (EID) via ultrasound before and after 8-week vitamin (folic acid, B12, B6) or placebo supplementation.
Main Results:
- Hyperhomocysteinemic subjects had lower baseline vitamin B12 levels.
- Vitamin supplementation significantly reduced plasma tHcy and increased serum folic acid and vitamin B12 levels in supplemented groups.
- No significant improvement in endothelial-dependent dilatation (EDD) or antithrombotic function was observed after vitamin treatment.
Conclusions:
- Mild hyperhomocysteinemia is not associated with endothelial dysfunction in young males lacking other cardiovascular risk factors.
- Vitamin-induced reduction of tHcy did not improve endothelial function in this cohort.
- The study suggests a stronger relationship between tHcy levels and vitamin B12 status compared to folic acid.
Background:
The relationship between hyperhomocysteinemia and cardiovascular disease has not been totally elucidated.
Hypothesis:
The study aimed to verify the association between hyperhomocysteinemia and endothelial dysfunction before and after modification of total homocysteine (tHcy) serum levels with vitamin supplementation in young male subjects devoid of any other cardiovascular risk factor.
Methods:
Twenty hyperhomocysteinemic (tHcy > 15 [micromol/l) male volunteers (< or = 40 years) and 20 age-matched subjects with normal tHcy levels (tHcy < 13 micromol/l) were included. Exclusion criteria were smoking, hypertension, diabetes, vitamin ingestion, obesity, hypercholesterolemia, renal failure, and positive antiphospholipid antibodies. Serum tHcy, folate, vitamin B12 levels, activated protein C and S, protein C resistance, fibrinogen, prothrombin, thrombin, antithrombin III, and in vitro oxidation of low-density lipoprotein (LDL) particles were measured. Noninvasive ultrasound measurements of endothelium-dependent (EDD) and -independent dilatation (EID) of the brachial artery were performed. Each pair was then randomly assigned to receive a vitamin capsule (0.6 mg folic acid, 0.8 mg B12. and 2.0 mg B6) oran identical placebo during 8 weeks, in a double-blind study design. After the treatment phase, blood samples and vascular reactivity were repeated.
Results:
Nine pairs of volunteers received vitamins and 11 received placebo. Hyperhomocysteinemic subjects had lower baseline serum levels of vitamin B12. Serum folate levels, antithrombotic function, in vitro LDL oxidation, and EDD were similar in all groups. After the vitamin supplementation, serum folic acid levels increased significantly both in normo- and hyperhomocysteinemic subjects, unlike vitamin B12, which increased only in the hyperhomocysteinemic individuals. Plasma tHcy decreased significantly in the supplemented groups. Treatment with vitamins was not associated with improvement in EDD or antithrombotic function.
Conclusions:
Mild hyperhomocysteinemia is not associated with endothelial dysfunction in young male subjects with no additional cardiovascular risk factors, and reduction of tHcy by vitamin supplementation does not modify EDD in this age group. In this sample, tHcy was more related to vitamin B12 than to folic acid status.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Vitamins
Bioavailability Study Design: Healthy Subjects Versus Patients
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

